PIN1 in breast development and cancer: a clinical perspective.

Cell Death Differ

National Laboratory CIB (LNCIB), Area Science Park, Padriciano 99, Trieste 34149, Italy.

Published: February 2017

Mammary gland development, various stages of mammary tumorigenesis and breast cancer progression have the peptidyl-prolyl cis/trans isomerase PIN1 at their centerpiece, in virtue of the ability of this unique enzyme to fine-tune the dynamic crosstalk between multiple molecular pathways. PIN1 exerts its action by inducing conformational and functional changes on key cellular proteins, following proline-directed phosphorylation. Through this post-phosphorylation signal transduction mechanism, PIN1 controls the extent and direction of the cellular response to a variety of inputs, in physiology and disease. This review discusses PIN1's roles in normal mammary development and cancerous progression, as well as the clinical impact of targeting this enzyme in breast cancer patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299711PMC
http://dx.doi.org/10.1038/cdd.2016.122DOI Listing

Publication Analysis

Top Keywords

breast cancer
8
pin1
4
pin1 breast
4
breast development
4
development cancer
4
cancer clinical
4
clinical perspective
4
perspective mammary
4
mammary gland
4
gland development
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!